Datamonitor, Oct 2011, Pages: 70
Merck KGaA: PharmaVitae Report This analysis examines the historical and forecast performance for Merck KGaA in the prescription pharmaceutical sector. The profile encompasses global company strategy
Datamonitor, June 2011, Pages: 199
attractiveness
Rebif (interferon beta-1a; MerckSerono)
Drug profile
Development overview
SWOT analysis
Satisfaction of unmet needs
Product positioning
Clinical and
NeuroInsights, May 2011, Pages: 500+
Protection
Patent Expirations
Patent Activity in the United States3: Neuropharmaceutical Sector
Neuropharmaceutical Sector Overview
Trends in Neuropharmaceuticals
Spotlight on Big Pharma
NeuroInsights, May 2010
in the United States3: Neuropharmaceutical Sector
Neuropharmaceutical Sector Overview
Trends in Neuropharmaceuticals
Spotlight on Big Pharma
Neuropharmaceutical Partnering and Licensing